Javier Vargas‐Medrano

451 total citations
26 papers, 364 citations indexed

About

Javier Vargas‐Medrano is a scholar working on Molecular Biology, Neurology and Neurology. According to data from OpenAlex, Javier Vargas‐Medrano has authored 26 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Neurology and 9 papers in Neurology. Recurrent topics in Javier Vargas‐Medrano's work include Parkinson's Disease Mechanisms and Treatments (9 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers) and Sphingolipid Metabolism and Signaling (5 papers). Javier Vargas‐Medrano is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (9 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers) and Sphingolipid Metabolism and Signaling (5 papers). Javier Vargas‐Medrano collaborates with scholars based in United States, Mexico and China. Javier Vargas‐Medrano's co-authors include Ruth G. Perez, Barbara Yang, Bharathi S. Gadad, David X. Medina, Paul M. Thompson, Manuel Miranda, Vicente Castrejón-Téllez, Chinnasamy Ramesh, Jeffrey B. Arterburn and Haiyan Lou and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Javier Vargas‐Medrano

24 papers receiving 359 citations

Peers

Countries citing papers authored by Javier Vargas‐Medrano

Since Specialization

Citations

This map shows the geographic impact of Javier Vargas‐Medrano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Vargas‐Medrano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Vargas‐Medrano more than expected).

Fields of papers citing papers by Javier Vargas‐Medrano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Vargas‐Medrano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Vargas‐Medrano. The network helps show where Javier Vargas‐Medrano may publish in the future.

Co-authorship network of co-authors of Javier Vargas‐Medrano

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Vargas‐Medrano. A scholar is included among the top collaborators of Javier Vargas‐Medrano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Vargas‐Medrano. Javier Vargas‐Medrano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploratory study of the dysregulation of age-related changes in neural/glial antigen 2 and neuroinflammation markers in individuals with major depression 2025 ·Brain Behavior & Immunity - Health ·Javier Vargas‐Medrano, (unknown), (unknown), P. Thompson	1
2	Sex and diet-dependent gene alterations in human and rat brains with a history of nicotine exposure 2023 ·Frontiers in Psychiatry ·Javier Vargas‐Medrano, (unknown), (unknown), Zuber D. Mulla, (unknown), (unknown), (unknown), (unknown), Sergio D. Iñiguez, Paul M. Thompson, Laura E. O’Dell, Bharathi S. Gadad	2
3	Association of ADHD and Obesity in Hispanic Children on the US-Mexico Border: A Retrospective Analysis 2022 ·Frontiers in Integrative Neuroscience ·(unknown), (unknown), Kiran Chaudhary, Luis Alvarado, Sergio D. Iñiguez, Javier Vargas‐Medrano, (unknown), (unknown), Bharathi S. Gadad, (unknown)	3
4	Gene Expression Analysis of CCL2, MOBP and OPALIN in Major Depressive Disorder and Suicidality (P5-6.005) 2022 ·Neurology ·Rui Tang, Javier Vargas‐Medrano, Enrique Ramos, Paul M. Thompson, Bharathi S. Gadad	1
5	Multiple Sclerosis-associated Bacterial Ligand 654 2021 ·Archives of Medical Research ·Jordan Brown, (unknown), (unknown), Javier Vargas‐Medrano, Bharathi S. Gadad, Frank C. Nichols, Jorge Cervantes	5
6	Cypermethrin, deltamethrin and glyphosate affect the activity of the Ca2 +-ATPase from human erythrocyte 2020 ·SHILAP Revista de lepidopterología ·Javier Vargas‐Medrano, (unknown), (unknown), (unknown)	0
7	Psychological and neurobiological aspects of suicide in adolescents: Current outlooks 2020 ·Brain Behavior & Immunity - Health ·Javier Vargas‐Medrano, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sadhana Chheda, Paul M. Thompson, Bharathi S. Gadad	24
8	FTY720-Mitoxy reduces synucleinopathy and neuroinflammation, restores behavior and mitochondria function, and increases GDNF expression in Multiple System Atrophy mouse models 2019 ·Experimental Neurology ·(unknown), (unknown), Barbara Yang, (unknown), (unknown), (unknown), (unknown), Javier Vargas‐Medrano, Ruth G. Perez	20
9	FTY720 Improves Behavior, Increases Brain Derived Neurotrophic Factor Levels and Reduces α-Synuclein Pathology in Parkinsonian GM2 +/− Mice 2019 ·Neuroscience ·(unknown), (unknown), (unknown), (unknown), Barbara Yang, Javier Vargas‐Medrano, (unknown), Ruth G. Perez	36
10	FTY720-Mitoxy reduces toxicity associated with MSA-like α-synuclein and oxidative stress by increasing trophic factor expression and myelin protein in OLN-93 oligodendroglia cell cultures 2019 ·Neuropharmacology ·Javier Vargas‐Medrano, (unknown), Barbara Yang, Chinnasamy Ramesh, Jeffrey B. Arterburn, Ruth G. Perez	12
11	Chlorpromazine and dimethyl sulfoxide modulate the catalytic activity of the plasma membrane Ca2+-ATPase from human erythrocyte 2018 ·Journal of Bioenergetics and Biomembranes ·(unknown), (unknown), Ángel G. Díaz‐Sánchez, (unknown), Javier Vargas‐Medrano, (unknown)	7
12	Could α-Synuclein Modulation of Insulin and Dopamine Identify a Novel Link Between Parkinson’s Disease and Diabetes as Well as Potential Therapies? 2018 ·Frontiers in Molecular Neuroscience ·(unknown), Barbara Yang, Javier Vargas‐Medrano, Ruth G. Perez	13
13	Up-regulation of protective neuronal MicroRNAs by FTY720 and novel FTY720-derivatives 2018 ·Neuroscience Letters ·Javier Vargas‐Medrano, Barbara Yang, (unknown), (unknown), Ruth G. Perez	18
14	FTY720-derivatives do not induce FTY720-like lymphopenia 2017 ·Journal of Pharmacological Sciences ·(unknown), (unknown), (unknown), Javier Vargas‐Medrano, Ruth G. Perez	11
15	FTY720 (Fingolimod) reverses α-synuclein-induced downregulation of brain-derived neurotrophic factor mRNA in OLN-93 oligodendroglial cells 2017 ·Neuropharmacology ·(unknown), Barbara Yang, Javier Vargas‐Medrano, Ruth G. Perez	30
16	Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays 2017 ·Journal of Visualized Experiments ·(unknown), Javier Vargas‐Medrano, Ernesto Villanueva, Brian S. Marcus, (unknown), Ruth G. Perez	6
17	FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice 2016 ·Journal of Biological Chemistry ·(unknown), Javier Vargas‐Medrano, (unknown), David X. Medina, (unknown), Barbara Yang, (unknown), (unknown), Ruth G. Perez	63
18	1,2-Dichlorobenzene affects the formation of the phosphoenzyme stage during the catalytic cycle of the Ca2+-ATPase from sarcoplasmic reticulum 2016 ·BMC Biochemistry ·Javier Vargas‐Medrano, (unknown), (unknown)	3
19	PKC-Dependent GlyT1 Ubiquitination Occurs Independent of Phosphorylation: Inespecificity in Lysine Selection for Ubiquitination 2015 ·PLoS ONE ·(unknown), Vicente Castrejón-Téllez, (unknown), Elisa Robles‐Escajeda, Javier Vargas‐Medrano, Armando Varela‐Ramírez, Manuel Miranda	11
20	PKCβ-dependent phosphorylation of the glycine transporter 1 2011 ·Neurochemistry International ·Javier Vargas‐Medrano, Vicente Castrejón-Téllez, (unknown), (unknown), Manuel Miranda	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact